HK1105871A1 - Composition containing statins and omega-3 fatty acids - Google Patents
Composition containing statins and omega-3 fatty acidsInfo
- Publication number
- HK1105871A1 HK1105871A1 HK07111294.3A HK07111294A HK1105871A1 HK 1105871 A1 HK1105871 A1 HK 1105871A1 HK 07111294 A HK07111294 A HK 07111294A HK 1105871 A1 HK1105871 A1 HK 1105871A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- omega
- fatty acids
- composition containing
- containing statins
- statins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000395A ITRM20040395A1 (it) | 2004-08-03 | 2004-08-03 | Composizione comprendente statine e acidi grassi omega 3. |
PCT/IT2005/000414 WO2006013602A1 (en) | 2004-08-03 | 2005-07-19 | Composition containing statins and omega-3 fatty acids |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1105871A1 true HK1105871A1 (en) | 2008-02-29 |
Family
ID=35124288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07111294.3A HK1105871A1 (en) | 2004-08-03 | 2007-10-18 | Composition containing statins and omega-3 fatty acids |
Country Status (22)
Country | Link |
---|---|
US (1) | US8853229B2 (ru) |
EP (1) | EP1773312B1 (ru) |
JP (1) | JP5103179B2 (ru) |
KR (1) | KR101355122B1 (ru) |
CN (1) | CN1993119B (ru) |
AU (1) | AU2005268402B2 (ru) |
BR (1) | BRPI0514026A (ru) |
CA (1) | CA2573000C (ru) |
CY (1) | CY1115416T1 (ru) |
DK (1) | DK1773312T3 (ru) |
EA (1) | EA014444B1 (ru) |
ES (1) | ES2481169T3 (ru) |
HK (1) | HK1105871A1 (ru) |
IL (1) | IL180602A (ru) |
IT (1) | ITRM20040395A1 (ru) |
MX (1) | MX2007001009A (ru) |
NZ (1) | NZ552396A (ru) |
PL (1) | PL1773312T3 (ru) |
PT (1) | PT1773312E (ru) |
SI (1) | SI1773312T1 (ru) |
WO (1) | WO2006013602A1 (ru) |
ZA (1) | ZA200701816B (ru) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1786414A4 (en) | 2004-08-06 | 2008-04-09 | Transform Pharmaceuticals Inc | NEW PHARMACEUTICAL STATIN COMPOSITIONS AND RELEVANT TREATMENT PROCEDURES |
DE102004063638A1 (de) * | 2004-12-31 | 2006-07-13 | Biosyn Arzneimittel Gmbh | Selen-haltige Medikamente zur Prophylaxe oder Therapie von endothelialen Gefäßerkrankungen |
BRPI0607569A2 (pt) * | 2005-03-08 | 2009-09-15 | Reliant Pharmaceuticals Inc | composição farmacêutica compreendendo estatina e ácidos graxos Èmega-3, na forma de dosagem unitária |
CN101365431A (zh) * | 2005-10-14 | 2009-02-11 | 帝斯曼知识产权资产管理有限公司 | 包含白藜芦醇的营养药物组合物的新颖用途 |
US8784886B2 (en) | 2006-03-09 | 2014-07-22 | GlaxoSmithKline, LLC | Coating capsules with active pharmaceutical ingredients |
US20080085911A1 (en) | 2006-10-10 | 2008-04-10 | Reliant Pharmaceuticals, Inc. | Statin and omega-3 fatty acids for reduction of apo-b levels |
DK2334295T3 (en) | 2008-09-02 | 2017-10-09 | Amarin Pharmaceuticals Ie Ltd | PHARMACEUTICAL COMPOSITION COMPREHENSIVE EICOSAPENTAIC ACID AND NICOTIC ACID AND PROCEDURES FOR USING SAME |
ITFI20080243A1 (it) * | 2008-12-15 | 2010-06-16 | Valpharma Sa | Formulazioni per la somministrazione orale di acidi grassi omega polienoici in combinazione con statine di origine naturale o semi-sintetica. |
LT3037089T (lt) | 2009-02-10 | 2020-01-10 | Amarin Pharmaceuticals Ireland Limited | Eikozapentaeno rūgšties etilo esteris skirtas hipertriglicidemijai gydydti |
WO2010127103A1 (en) | 2009-04-29 | 2010-11-04 | Amarin Pharma, Inc. | Stable pharmaceutical composition and methods of using same |
AU2010241567B2 (en) | 2009-04-29 | 2013-10-31 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same |
DK2440065T3 (en) * | 2009-06-12 | 2018-12-10 | Calanus As | COPYPOD OIL COMPOSITION, FORMULATIONS CONTAINING THE OIL COMPOSITION, AND ITS APPLICATION FOR REDUCING VISCAL FAT COLLECTION, IMPROVEMENT OF GLUCOSET TOLERANCE AND PREVENTION OR TREATMENT OF PATIENTS |
US8455472B2 (en) | 2009-06-15 | 2013-06-04 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
KR101798670B1 (ko) * | 2009-09-23 | 2017-11-16 | 아마린 코포레이션 피엘씨 | 오메가-3 지방산 및 스타틴의 히드록시-유도체를 포함하는 제약 조성물 및 그의 사용 방법 |
SG10201408508YA (en) | 2009-12-23 | 2015-02-27 | Defiante Farmacêutica S A | Combination composition useful for treating cardiovascular diseases |
US8557236B2 (en) * | 2010-02-09 | 2013-10-15 | Vascure Natural LLC | Cardiovascular support supplement and compositions and methods thereof |
US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
NZ727980A (en) | 2010-11-29 | 2018-08-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
WO2012087487A1 (en) | 2010-12-20 | 2012-06-28 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
AU2015201809B2 (en) * | 2010-12-20 | 2016-09-29 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
KR101310710B1 (ko) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | 오메가-3 지방산 에스테르 및 HMG-CoA 환원효소 억제제를 포함하는 경구용 복합 조성물 |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
US20130131170A1 (en) | 2011-11-07 | 2013-05-23 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
EP2800469B1 (en) | 2012-01-06 | 2021-08-25 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject |
MY189576A (en) * | 2012-03-30 | 2022-02-17 | Micelle Biopharma Inc | Omega-3 fatty acid ester compositions |
US9682093B2 (en) | 2012-03-30 | 2017-06-20 | Charles R. Drew University Of Medicine And Science | Compositions and methods for treating or preventing metabolic syndrome disorders |
RS61557B1 (sr) | 2012-06-29 | 2021-04-29 | Amarin Pharmaceuticals Ie Ltd | Postupci za smanjenje rizika od kardiovaskularnog događaja kod pacijenta na terapiji statinom primenom etil estra eikozapentaenske kiseline |
WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
WO2015003246A1 (en) * | 2013-07-09 | 2015-01-15 | Mcmaster University | Combination of a statin with an inflammasome inhibitor |
US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
RU2554806C1 (ru) * | 2014-07-29 | 2015-06-27 | государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СибГМУ Минздрава России) | Способ коррекции повышенного уровня тревоги и депрессии у пациентов с артериальной гипертонией на фоне сахарного диабета 2 типа |
CN104922160A (zh) * | 2015-05-22 | 2015-09-23 | 舟山三合生物科技有限公司 | 他汀与Omega-3脂肪酸和辅酶Q10复配的组合物及其应用 |
US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
ITUA20162575A1 (it) | 2016-04-13 | 2017-10-13 | S&R Farm S P A | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
US10966951B2 (en) | 2017-05-19 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
WO2020068163A1 (en) | 2018-09-24 | 2020-04-02 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
KR20240012390A (ko) | 2021-04-21 | 2024-01-29 | 애머린 파마슈티칼스 아일랜드 리미티드 | 심부전의 위험을 감소시키는 방법 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1055638C (zh) | 1995-07-14 | 2000-08-23 | 李江 | 富硒虫草口服液及其制备方法 |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
US20030228393A1 (en) * | 2002-05-31 | 2003-12-11 | Zhao Iris Ginron | Multi-phase food & beverage |
CN1061259C (zh) * | 1998-11-24 | 2001-01-31 | 彭素萍 | 藜蒿中生物活性物质的富集物及用途 |
WO2002043659A2 (en) * | 2000-11-29 | 2002-06-06 | Smithkline Beecham Corporation | Composition containing statins and calcium for improved cardiovascular health |
US20050002992A1 (en) * | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
US20020182585A1 (en) * | 2001-01-10 | 2002-12-05 | George Kindness | Combination and method using EDTA, cystine, zinc and selenium for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy |
US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
US20040018248A1 (en) * | 2001-11-29 | 2004-01-29 | Adrianne Bendich | Composition containing statins and calcium for improved cardiovascular health |
US6855353B2 (en) * | 2002-03-08 | 2005-02-15 | Yaguang Liu | Method for producing antioxidant and prevention of cancer |
AU2003266287A1 (en) * | 2002-08-23 | 2004-03-11 | Dsm Ip Assets B.V. | Novel nutraceutical compositions comprising biotin |
WO2004028469A2 (en) * | 2002-09-27 | 2004-04-08 | Martek Biosciences Corporation | Docohexaenoic acid for improved glycemic control |
CN1694695A (zh) * | 2002-11-07 | 2005-11-09 | 帝斯曼知识产权资产管理有限公司 | 包含表没食子儿茶素没食子酸酯的新颖的营养药物性组合物 |
-
2004
- 2004-08-03 IT IT000395A patent/ITRM20040395A1/it unknown
-
2005
- 2005-07-19 CA CA2573000A patent/CA2573000C/en not_active Expired - Fee Related
- 2005-07-19 PL PL05769486T patent/PL1773312T3/pl unknown
- 2005-07-19 MX MX2007001009A patent/MX2007001009A/es active IP Right Grant
- 2005-07-19 AU AU2005268402A patent/AU2005268402B2/en not_active Ceased
- 2005-07-19 US US11/632,953 patent/US8853229B2/en not_active Expired - Fee Related
- 2005-07-19 JP JP2007524466A patent/JP5103179B2/ja not_active Expired - Fee Related
- 2005-07-19 EA EA200700240A patent/EA014444B1/ru not_active IP Right Cessation
- 2005-07-19 SI SI200531865T patent/SI1773312T1/sl unknown
- 2005-07-19 ES ES05769486.1T patent/ES2481169T3/es active Active
- 2005-07-19 PT PT57694861T patent/PT1773312E/pt unknown
- 2005-07-19 NZ NZ552396A patent/NZ552396A/en not_active IP Right Cessation
- 2005-07-19 CN CN2005800258385A patent/CN1993119B/zh not_active Expired - Fee Related
- 2005-07-19 KR KR1020077004538A patent/KR101355122B1/ko not_active IP Right Cessation
- 2005-07-19 WO PCT/IT2005/000414 patent/WO2006013602A1/en active Application Filing
- 2005-07-19 DK DK05769486.1T patent/DK1773312T3/da active
- 2005-07-19 BR BRPI0514026-9A patent/BRPI0514026A/pt not_active Application Discontinuation
- 2005-07-19 EP EP05769486.1A patent/EP1773312B1/en active Active
-
2007
- 2007-01-08 IL IL180602A patent/IL180602A/en not_active IP Right Cessation
- 2007-03-01 ZA ZA200701816A patent/ZA200701816B/en unknown
- 2007-10-18 HK HK07111294.3A patent/HK1105871A1/xx not_active IP Right Cessation
-
2014
- 2014-07-16 CY CY20141100583T patent/CY1115416T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR101355122B1 (ko) | 2014-02-04 |
EA014444B1 (ru) | 2010-12-30 |
DK1773312T3 (da) | 2014-07-21 |
CA2573000A1 (en) | 2006-02-09 |
PL1773312T3 (pl) | 2014-09-30 |
BRPI0514026A (pt) | 2008-05-27 |
PT1773312E (pt) | 2014-07-25 |
US8853229B2 (en) | 2014-10-07 |
EP1773312B1 (en) | 2014-05-07 |
CN1993119A (zh) | 2007-07-04 |
WO2006013602A1 (en) | 2006-02-09 |
JP2008509132A (ja) | 2008-03-27 |
IL180602A0 (en) | 2008-03-20 |
JP5103179B2 (ja) | 2012-12-19 |
ZA200701816B (en) | 2008-07-30 |
EP1773312A1 (en) | 2007-04-18 |
NZ552396A (en) | 2009-08-28 |
AU2005268402B2 (en) | 2010-08-26 |
IL180602A (en) | 2015-06-30 |
SI1773312T1 (sl) | 2014-08-29 |
EA200700240A1 (ru) | 2007-06-29 |
ES2481169T3 (es) | 2014-07-29 |
KR20070058460A (ko) | 2007-06-08 |
MX2007001009A (es) | 2007-04-16 |
CY1115416T1 (el) | 2017-01-04 |
CN1993119B (zh) | 2011-04-06 |
ITRM20040395A1 (it) | 2004-11-03 |
CA2573000C (en) | 2014-03-11 |
US20080089876A1 (en) | 2008-04-17 |
AU2005268402A1 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL180602A0 (en) | Composition containing statins and omega-3 fatty acids | |
EP1801096A4 (en) | POLYGLYCERIN FUEL ACID AND THE COMPOSITIONS CONTAINING THEREOF | |
EP1861087A4 (en) | TREATMENT WITH STATINE AND OMEGA-3-FATTY ACID AS A COMBINATION PRODUCT THEREOF | |
HK1102348A1 (en) | Composition containing polyglycerol/medium-chain fatty acid ester | |
EP1685218A4 (en) | Fatty acid esters and their use | |
IL174925A0 (en) | Glycerophospholipids containing omega -3 and omega-6 fatty acids | |
EP2083815A4 (en) | STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCING APO-B MIRRORS | |
ZA200709252B (en) | N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use | |
IL183246A0 (en) | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same | |
EP1958612A4 (en) | TREHALOSE FATTY ACID ESTER COMPOSITION | |
PL1699449T3 (pl) | Zastosowanie kompozycji kwasów tłuszczowych obejmującej co najmniej jeden z EPA i DHA lub jakąkolwiek ich kombinację | |
PL377614A1 (pl) | Kompozycje zawierające kwasy tłuszczowe i aminokwasy | |
HK1132433A1 (en) | Nutritional supplement containing long-chain polyunsaturated fatty acids | |
EP2089014A4 (en) | OMEGA-3 FATTY ACIDS AND DYSLIPIDEMIC AGENT FOR REDUCING APO-B LEVELS | |
ZA200802457B (en) | Method for extending the shelf-life of food compositions containing polyunsaturated fatty acids | |
ZA201003030B (en) | Medium-chain length fatty acids and glycerides as nephroprotection agents | |
GB0625737D0 (en) | Compositions comprising polyunsaturated fatty acids | |
PL2214638T3 (pl) | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe i węgiel aktywny | |
ZA200609727B (en) | Carbonylation of ester | |
EP1617830A4 (en) | ESTERIFIED FATTY ACID COMPOSITION | |
HK1100440A1 (en) | Pharmaceutical composition comprising temozolomide ester | |
EP1718156A4 (en) | COMPOSITIONS AND METHODS FOR ALTERING POLYUNSATURATED FATTY ACID CONTENT OF BIOLOGICAL CELLS | |
HUP0402490A2 (en) | Antiviral and immunestimulant pharmaceutical composition containing polyunsaturated fatty acid esters | |
GB0402146D0 (en) | Extraction of fatty acids | |
GB0411164D0 (en) | Extraction of essential fatty acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170719 |